Veterinary Medicines

KEFAMAST Dry Cow Intramammary Suspension

Authorised
  • Cefalexin
  • Dihydrostreptomycin sulfate
Download as PDF

Product identification

Medicine name:
KEFAMAST Dry Cow Intramammary Suspension
Active substance:
  • Cefalexin
  • Dihydrostreptomycin sulfate
Target species:
  • Cattle
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Cefalexin
    500.00
    milligram(s)
    /
    1.00
    Syringe
  • Dihydrostreptomycin sulfate
    584.05
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle
      • Meat and offal
        28
        day
      • Milk
        1020
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RD01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • A sterile intramammary injection provided in 10 ml white low density polyethylene syringe for single use only. Packaged inbuckets of 120 syringes.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Informed consent (abridged application) - Council Directive 81/851/EEC
Marketing authorisation holder:
  • Bimeda Animal Health Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bimeda Animal Health Limited
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA22033/041/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download